Clinical Trial Update: Clinical Trial to Evaluate the Chronic Efficacy of OC-01 Nasal Spray on Signs of Dry Eye Disease (The MYSTIC Study) [Phase 2]

View source ↗

Summary

Phase 2 trial update for OC-01 nasal spray (MYSTIC Study) evaluating chronic efficacy on signs of dry eye disease; study completed with results posted.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Dry Eye Disease

Drugs mentioned

• OC-01 Nasal Spray (varenicline)

Snippet

Sponsor: Oyster Point Pharma, Inc. | Conditions: Dry Eye Disease | Phase 2 | Status: COMPLETED | Results posted: 2022-06-08